Application of Individualized Treatment Strategies for CLL/SLL

In this slideset and commentary CLL/SLL experts discuss multiple new drug approvals promising clinical trials novel mechanisms of action and how to integrate these new approaches into individual patient management.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

BeiGene

Janssen administered by Scientific Affairs

Pharmacyclics an AbbVie Company